Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease.

By T. Seemungal, R. Harper-Owen, A. Bhowmik, I. Moric, G. Sanderson, S. Message, P. Maccallum, T. Meade, D. Jeffries, S. Johnston and 1 more. American Journal of Respiratory and Critical Care Medicine, 2001

1,079 citations recorded by the source corpus.

Subfields: Epidemiology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/2131e9de59f57e38814ad576b4ffe32e29464c00

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

T. Walsh

In Pulmonary and Respiratory Medicine

Citations in the corpus

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (2007, background): “The infectious agents in COPD exacerbations can be viral or bacterial (140, 239).”
Human Rhinoviruses (2013, background): “In the outpatient setting, approximately twothirds of AECOPD cases are associated with common cold symptoms (increased nasal congestion and/or increased rhinorrhea) in the 18 days preceding the onset of the exacerbation, and HRV remains the most common cause of viral infection (151).”
Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease (2003, background): “Considering that several weeks of convalescence may be needed to recover from a single exacerbation, perhaps 6–8 weeks for full recovery [26], the reduction in exacerbation rate with budesonide/ formoterol could be considered clinically and economically important.”
Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. (2012, neutral): “9) CRP, mg/L 5 (10) 9 (22) 3 (9) 3 (6)”
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. (2006, background): “Antiviral therapy may have a role in at least half and probably two-thirds of exacerbations (as 65% of patients report common cold symptoms in the week preceding exacerbation [23]), and a combined antibacterial and antiviral strategy in at least one-quarter of exacerbations (i.”
Guidelines for the management of adult lower respiratory tract infections - Full version (2011, neutral): “[171] Serology Culture 168 0 0.”
Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution (2023, neutral): “Хотя при обострениях ХОБЛ опреде" ленную роль играют вирусные или бактериальные ин" фекции [273, 436], вопрос применения антибиотиков для лечения обострений по"прежнему неоднозначен [569].”